The Journal of Neuroscience, November 15, 2002, 22(22):9810-9820
Ammonium-Induced Impairment of Axonal Growth Is Prevented through
Glial Creatine
Olivier
Braissant1, *,
Hugues
Henry1, *,
Anne-Marie
Villard1,
Marie-Gabrielle
Zurich2,
Marc
Loup1,
Barbara
Eilers1,
Gianni
Parlascino1,
Edouard
Matter1,
Olivier
Boulat1,
Paul
Honegger2, and
Claude
Bachmann1
1 Clinical Chemistry Laboratory, University Hospital,
CH-1011 Lausanne, Switzerland, and 2 Institute of
Physiology, University of Lausanne, CH-1005 Lausanne, Switzerland
Hyperammonemia in neonates and infants affects brain development
and causes mental retardation. We report that ammonium
impaired cholinergic axonal growth and altered localization and
phosphorylation of intermediate neurofilament protein in rat
reaggregated brain cell primary cultures. This effect was restricted to
the phase of early maturation but did not occur after synaptogenesis.
Exposure to NH4Cl decreased intracellular creatine,
phosphocreatine, and ADP. We demonstrate that creatine cotreatment
protected axons from ammonium toxic effects, although this did not
restore high-energy phosphates. The protection by creatine was glial
cell-dependent. Our findings suggest that the means to efficiently
sustain CNS creatine concentration in hyperammonemic neonates and
infants should be assessed to prevent impairment of axonogenesis and
irreversible brain damage.
Key words:
hyperammonemia; axon; creatine; glia; neurofilament; phosphorylation
*
O.B. and H.H. contributed equally to this work.